Arcus Biosciences (RCUS) Long-Term Investments: 2017-2025
Historic Long-Term Investments for Arcus Biosciences (RCUS) over the last 7 years, with Sep 2025 value amounting to $10.0 million.
- Arcus Biosciences' Long-Term Investments rose 400.00% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year increase of 400.00%. This contributed to the annual value of $14.0 million for FY2024, which is 86.92% down from last year.
- Arcus Biosciences' Long-Term Investments amounted to $10.0 million in Q3 2025, which was down 37.50% from $16.0 million recorded in Q2 2025.
- Arcus Biosciences' Long-Term Investments' 5-year high stood at $218.7 million during Q3 2021, with a 5-year trough of $2.0 million in Q3 2024.
- Its 3-year average for Long-Term Investments is $56.2 million, with a median of $40.0 million in 2024.
- Its Long-Term Investments has fluctuated over the past 5 years, first skyrocketed by 8,001.11% in 2021, then slumped by 98.68% in 2024.
- Arcus Biosciences' Long-Term Investments (Quarterly) stood at $182.0 million in 2021, then declined by 29.12% to $129.0 million in 2022, then fell by 17.05% to $107.0 million in 2023, then slumped by 86.92% to $14.0 million in 2024, then spiked by 400.00% to $10.0 million in 2025.
- Its Long-Term Investments stands at $10.0 million for Q3 2025, versus $16.0 million for Q2 2025 and $8.0 million for Q1 2025.